APSR2026-266

Yes
Late-Breaking
Submitted
Oral Presentation
AO20-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1216626-46903-APSR2026-266_439782.pptx
Format: PPTX Only
 
Format: PDF Only
15. Pulmonary Circulation
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Lei Wang * The Second Affiliated Hospital of Xi’an Jiaotong University Department of Respiratory and Critical Care Medicine xi'an China
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Lei
Wang
wl860806wb@163.com
+8613167512899
31-40
China
Original Research
Stabilization of IL-33 by Cullin 5-driven K63 Ubiquitination Underlies Endothelial Injury in Pulmonary Vascular Remodeling
Maximum 25 words
Abstract Content
Pulmonary vascular remodeling (PVR) is a key pathological feature of pulmonary hypertension (PH). Endothelial injury initiates PVR, yet the underlying molecular mechanisms remain incompletely understood. This study aims to investigate the molecular mechanism of endothelial Cul5 and IL-33 interaction in endothelial dysfunction-mediated PVR, providing a potential new therapeutic target for PH.
PH was induced in 8-week-old male C57BL/6 WT, Il-33-/-, and Cul5+/- mice using the SU5416 combined with hypoxia (SuHx) model. Post-modeling, right heart hemodynamics were assessed via small-animal ultrasound; right ventricular systolic pressure (RVSP) was measured using a ventricular pressure-volume system; pulmonary vascular remodeling was evaluated by H&E and α-SMA immunofluorescence staining; and right ventricular hypertrophy was assessed by WGA staining. Western Blot, immunofluorescence, co-immunoprecipitation (Co-IP), GST-Pulldown, and molecular docking were used to validate Cul5 and IL-33 expression and interaction. The regulation of IL-33 protein stability and half-life by Cul5 was determined via Western Blot with CHX/MG132 treatment, revealing its ubiquitination modification pattern (K63- or K48-linked). Truncated plasmids (WT/Mutant-Cul5) combined with Co-IP/GST-Pulldown were employed to identify the key interacting domains between Cul5 and IL-33.
Genetic knockout of either IL-33 or Cul5 significantly alleviated SuHx-induced PH. Both Cul5 and IL-33 expression were detected in the endothelium of PH mouse lungs and in human pulmonary arterial endothelial cells (HPAECs). Cul5 promoted endothelial IL-33 expression, whereas IL-33 did not affect Cul5 expression. An IL-33-neutralizing antibody reversed Cul5-mediated endothelial dysfunction (angiogenesis, adhesion, apoptosis). Co-IP and GST-Pulldown experiments confirmed a direct interaction between endothelial Cul5 and IL-33, further supported by molecular docking predictions indicating interaction sites involving lysine ubiquitination sites. As an E3 ubiquitin ligase, Cul5 regulated IL-33 protein stability via K63-linked ubiquitination. The N-terminal domain of Cul5 was identified as critical for its interaction with IL-33.
During PH pathogenesis, endothelial Cul5, as part of the CRL5 complex, recognizes IL-33 and enhances its stability and activity through K63-linked ubiquitination at the post-translational level. This leads to upregulated endothelial IL-33 expression, ultimately contributing to endothelial injury-mediated PVR.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Cullin 5, IL-33, Pulmonary Vascular Remodeling
maximum 3 keywords and no abbreviations, separated by commas
This work was supported by National Natural Science Foundation of China (Grant No. 82270055). The authors declare no competing interests.
327